324 related articles for article (PubMed ID: 23261068)
1. Mutational landscape of AML with normal cytogenetics: biological and clinical implications.
Martelli MP; Sportoletti P; Tiacci E; Martelli MF; Falini B
Blood Rev; 2013 Jan; 27(1):13-22. PubMed ID: 23261068
[TBL] [Abstract][Full Text] [Related]
2. Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.
Falini B; Martelli MP
Best Pract Res Clin Haematol; 2015; 28(2-3):90-7. PubMed ID: 26590764
[TBL] [Abstract][Full Text] [Related]
3. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
4. Molecular genetic tests for FLT3, NPM1, and CEBPA in acute myeloid leukemia.
Zhang Q; Bai S; Vance GH
Methods Mol Biol; 2013; 999():105-21. PubMed ID: 23666693
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in AML in relation to (ab)normal karyotype.
Stone RM
Best Pract Res Clin Haematol; 2009 Dec; 22(4):523-8. PubMed ID: 19959103
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.
Ghanem H; Tank N; Tabbara IA
Am J Hematol; 2012 Jan; 87(1):69-77. PubMed ID: 22072438
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
8. Multiplex high-throughput gene mutation analysis in acute myeloid leukemia.
Dunlap J; Beadling C; Warrick A; Neff T; Fleming WH; Loriaux M; Heinrich MC; Kovacsovics T; Kelemen K; Leeborg N; Gatter K; Braziel RM; Press R; Corless CL; Fan G
Hum Pathol; 2012 Dec; 43(12):2167-76. PubMed ID: 22658276
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization of acute myeloid leukemia.
Döhner K; Döhner H
Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
[No Abstract] [Full Text] [Related]
10. Clinically useful prognostic factors in acute myeloid leukemia.
Ferrara F; Palmieri S; Leoni F
Crit Rev Oncol Hematol; 2008 Jun; 66(3):181-93. PubMed ID: 17996460
[TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics.
Gaidzik V; Döhner K
Semin Oncol; 2008 Aug; 35(4):346-55. PubMed ID: 18692685
[TBL] [Abstract][Full Text] [Related]
12. Combined molecular and clinical prognostic index for relapse and survival in cytogenetically normal acute myeloid leukemia.
Pastore F; Dufour A; Benthaus T; Metzeler KH; Maharry KS; Schneider S; Ksienzyk B; Mellert G; Zellmeier E; Kakadia PM; Unterhalt M; Feuring-Buske M; Buske C; Braess J; Sauerland MC; Heinecke A; Krug U; Berdel WE; Buechner T; Woermann B; Hiddemann W; Bohlander SK; Marcucci G; Spiekermann K; Bloomfield CD; Hoster E
J Clin Oncol; 2014 May; 32(15):1586-94. PubMed ID: 24711548
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association.
Renneville A; Boissel N; Nibourel O; Berthon C; Helevaut N; Gardin C; Cayuela JM; Hayette S; Reman O; Contentin N; Bordessoule D; Pautas C; Botton Sd; Revel Td; Terre C; Fenaux P; Thomas X; Castaigne S; Dombret H; Preudhomme C
Leukemia; 2012 Jun; 26(6):1247-54. PubMed ID: 22289988
[TBL] [Abstract][Full Text] [Related]
14. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
15. Gene expression with prognostic implications in cytogenetically normal acute myeloid leukemia.
Baldus CD; Bullinger L
Semin Oncol; 2008 Aug; 35(4):356-64. PubMed ID: 18692686
[TBL] [Abstract][Full Text] [Related]
16. [Prognostic factors of acute myeloid leukemia].
Inokuchi K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
[No Abstract] [Full Text] [Related]
17. Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways.
Kohlmann A; Bullinger L; Thiede C; Schaich M; Schnittger S; Döhner K; Dugas M; Klein HU; Döhner H; Ehninger G; Haferlach T
Leukemia; 2010 Jun; 24(6):1216-20. PubMed ID: 20428199
[No Abstract] [Full Text] [Related]
18. Translational implications of somatic genomics in acute myeloid leukaemia.
Meyer SC; Levine RL
Lancet Oncol; 2014 Aug; 15(9):e382-94. PubMed ID: 25079101
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
[TBL] [Abstract][Full Text] [Related]
20. [THE CLINICAL SIGNIFICANCE OF GENETIC MUTATIONS IN ACUTE MYELOID LEUKEMIA].
Goryainova NV
Lik Sprava; 2014 Dec; (12):10-8. PubMed ID: 26638462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]